21 Nov 2017
Venue: Aptuit, Verona, Italy
Date: Monday 10 September - Wednesday 12 September 2018
The key role of G protein-coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Aptuit, Italy will once again support the seventh meeting in this series on GPCR drug discovery, combining cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.
Applications are invited for both oral and poster presentations. Posters will be displayed through the meeting and applicants may indicate whether they wish to be considered for a flash oral presentation when submitting an abstract. For further information contact us by email. The abstract deadlines are Tuesday 2 January 2018 (oral) and Wednesday 11 July 2018 (poster).
Confirmed speakers include:
- Arthur Christopoulos
Monash University, Australia - Miles Congreve
Heptares Therapeutics, UK - Michael Hanson
GPCR Consortium, USA - Xiayang Qiu
Pfizer, USA - Daniel Rosenbaum
University of Texas Southwestern Medical Center, USA
This meeting presents a great opportunity for medicinal chemists, pharmacologists, computational chemists, structural biologists and all those involved in drug discovery to share knowledge and develop their professional networks. Discounted rates will be offered to RSC and SCI student members, and some student bursaries will be available on application. For further information contact us by email.
SCI members attending this meeting are able to claim CPD points.
Related Links
- 7th SCI/RSC Symposium on GPCRs in Medicinal Chemistry - call for papers!
- Oral Abstract Deadline: Tuesday 2 January 2018
- Poster Abstract Deadline: Wednesday 11 July 2018 - SCI Fine Chemicals Group
Visit Blog